Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06518551 |
| Title | Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Omar Nadeem, MD |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Brigham and Women's Hospital | NOT_YET_RECRUITING | Boston | Massachusetts | 02115 | United States | Details |
| Beth Israel Deaconess Medical Center | NOT_YET_RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| Dana Farber Cancer Institute | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |